Dr Reddys Laboratories Ltd

RDY chart

Dr Reddys Laboratories Ltd news

• RDY: SEC Form 6-K filed by Dr. Reddy's Laboratories Ltd

  Quantisnow · Nov 10, 1:36 PM EST

• Mumbai and London are planned stops for Dr. Reddy’s (RDY) investor meetings, subject to change.

  Stock Titan · Nov 10, 1:32 PM EST

• Dr Reddy's schedules investor meetings with JM Financial, Investec

  scanx.trade · Nov 10, 9:31 AM EST

• Revised Prices of Anti-Cancer Medicines to Come into Effect from 9th November;

  Odisha Diary · Nov 9, 1:57 AM EST

• Form 144 DR REDDYS LABORATORIES LTD For: 8 November By Investing.com

  Investing.com Nigeria · Nov 8, 7:17 PM EST

• Dr. Reddy's ANVISA approval opens Brazil semaglutide route

  Multibagg AI · Nov 5, 7:26 AM EST

• Brazil approves a once-weekly diabetes injection from Dr. Reddy’s (RDY).

  Stock Titan · Nov 5, 6:06 AM EST

• Dr. Reddy's Laboratories Ltd (RDY) Stock Forecasts

  Yahoo Finance · Nov 4, 11:51 PM EST

• RDY Q2 Earnings & Revenues Miss Estimates as Lenalidomide Sales Fall

  Yahoo Finance · Oct 26, 10:17 AM EDT

• Dr. Reddy's Laboratories Q2 Earnings Call Highlights

  marketbeat.com · Oct 23, 2:04 PM EDT

• Top Stock Reports for Oracle, American Express & Progressive

  Yahoo Finance · Oct 12, 3:24 PM EDT

• NBIX vs. TEVA: Which Drugmaker Is the Better Investment?

  Yahoo Finance · Aug 25, 1:26 PM EDT

Dr Reddys Laboratories Ltd key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-KFORM 6-K2026-11-10
• 6-KFORM 6-K2026-11-05
• 6-KFORM 6-K2026-11-04
• 6-KFORM 6-K2026-10-29
• 6-KFORM 6-K2026-10-29
• 6-KFORM 6-K2026-10-26
• 6-KFORM 6-K2026-10-26
• 6-KFORM 6-K2026-10-23
• 6-KFORM 6-K2026-10-23
• 6-KFORM 6-K2026-10-23
• 6-KFORM 6-K2026-10-23
• 6-KFORM 6-K2026-10-21

About Dr Reddys Laboratories Ltd

Ticker

RDY (NYSE)

Industry

Pharmaceutical Preparations

Headquarters

Hyderabad

Incorporated in

India

Fiscal year end

March 31

SEC CIK

1135951

Frequently asked questions